about
Ranolazine: A Contemporary ReviewUltrasound combined with targeted cationic microbubble-mediated angiogenesis gene transfection improves ischemic heart function.Cardiac shock-wave therapy in the treatment of coronary artery disease: systematic review and meta-analysisEvaluation of extracorporeal shock wave therapy for refractory angina pectoris with quantitative analysis using cardiac magnetic resonance imaging: a short communication.Cardiac shockwave therapy in patients with chronic refractory angina pectorisImpact of Cell Therapy on Myocardial Perfusion and Cardiovascular Outcomes in Patients With Angina Refractory to Medical Therapy: A Systematic Review and Meta-Analysis.Predictors of long-term clinical endpoints in patients with refractory anginaEffects of the intramyocardial implantation of stromal vascular fraction in patients with chronic ischemic cardiomyopathyThe Effectiveness and Cost-Effectiveness of Spinal Cord Stimulation for Refractory Angina (RASCAL Study): A Pilot Randomized Controlled TrialTreatment of refractory angina in patients not suitable for revascularization.Safety and efficacy of percutaneous intramyocardial bone marrow cell injection for chronic myocardial ischemia: Long-term results.Current State of Stem Cell Therapy for Ischemic Heart Disease.Epidemiology and pathogenesis of diffuse obstructive coronary artery disease: the role of arterial stiffness, shear stress, monocyte subsets and circulating microparticles.Percutaneous Device to Narrow the Coronary Sinus: Shifting Paradigm in the Treatment of Refractory Angina? A Review of the Literature.The coronary sinus reducer: clinical evidence and technical aspects.Autologous CD34<sup>+</sup> Cell Therapy for Refractory Angina: 2 year Outcomes from the ACT34-CMI Study.A prospective study of patients with refractory angina: outcomes and the role of high-sensitivity troponin T.Angiogenic gene therapy in cardiovascular diseases: dream or vision?The Athena trials: Autologous adipose-derived regenerative cells for refractory chronic myocardial ischemia with left ventricular dysfunction.Autologous CD34+ cell therapy improves exercise capacity, angina frequency and reduces mortality in no-option refractory angina: a patient-level pooled analysis of randomized double-blinded trials.The Reducer device in patients with angina pectoris: mechanisms, indications, and perspectives.Obstructive sleep apnoea is associated with myocardial injury in patients with refractory angina.Cell Therapy for Refractory Angina: A Reappraisal.A Novel Intra-aortic Device Designed for Coronary Blood Flow Amplification in Unrevascularizable Patients.Apheresis as novel treatment for refractory angina with raised lipoprotein(a): a randomized controlled cross-over trial.Usefulness of stellate ganglion block for refractory angina pectoris.New Advances in the Management of Refractory Angina PectorisLinking cell function with perfusion: insights from the transcatheter delivery of bone marrow-derived CD133 cells in ischemic refractory cardiomyopathy trial (RECARDIO)
P2860
Q26765421-C93ADB07-215C-4142-965A-E0A6AB14E037Q30355578-C1224298-8D03-475B-B371-17533018FCA1Q30358663-FA6FCF8D-DE3D-43C9-AAC6-97FFB01D3568Q30383943-478E6AE2-9B4E-4432-B378-82CFD66E1CDEQ30383948-AC56D31B-AD12-48FE-8ACD-D6CEEE3CF379Q30729604-71A9ECF6-0AB5-4357-B42F-0FF94D01F563Q35135665-FC1D1ED0-38B4-4C61-8620-49E09D0BB564Q36960036-4036608F-28CE-44F9-AC66-E8EC8129CEBEQ37320291-83E4D777-3FFF-4651-AE98-04D9BE316EDEQ38173640-38826693-0051-40A2-99E0-5C8D5C83FF79Q38655874-DD4A7CE9-19DD-4E1D-9B7B-97431583F70FQ38697092-F62C6D38-F4BF-4874-AA68-2225589D4472Q38860377-CA3AB8D8-D8ED-4125-8DCF-55B8FF4EDFE5Q39000547-61082138-5600-4354-A28E-001E319FF327Q39034193-68B8DC49-8D4A-40BE-BE27-448DC8AC13DCQ39790202-3459D20E-7FC3-463B-B598-425654B3AC18Q40535232-EB5DE387-F9C5-4D3A-A3F9-C48D5E95B946Q45863499-F4F97BA7-08B5-4BAE-9A30-096AD8643EC7Q46102792-AA1420E2-6CE6-4C5F-8503-07D190D2DCA2Q47190217-B64236BA-FDC0-46FA-A521-D1CE470073A5Q47579827-93FF5BFE-9139-43C6-A4B8-855C3C513C61Q47870837-02337C87-56E4-4763-A979-ABAA978F5CBCQ48155875-24DA5AF4-32F4-4D71-9F5F-0ABC8290F68AQ50633215-58D7F3D5-35C8-4C07-BE0D-293E7C36FB98Q53325503-62EFE9AB-2AC6-468A-BF81-A9F02A72857AQ55471360-B017647B-5DC2-4324-9142-C400E5C8236EQ57495833-CD85351E-A29E-4B80-AA30-06729CDC571FQ58741622-8195C074-6C04-494E-942F-F3B634A60122
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Long-term survival in patients with refractory angina.
@en
Long-term survival in patients with refractory angina.
@nl
type
label
Long-term survival in patients with refractory angina.
@en
Long-term survival in patients with refractory angina.
@nl
prefLabel
Long-term survival in patients with refractory angina.
@en
Long-term survival in patients with refractory angina.
@nl
P2093
P2860
P356
P1476
Long-term survival in patients with refractory angina.
@en
P2093
Alex R Campbell
Anil K Poulose
Bradley A Bart
Charlene R Boisjolie
Daniel Satran
James S Hodges
Jay H Traverse
Karen L Harvey
Rachel E Olson
Randall K Johnson
P2860
P304
P356
10.1093/EURHEARTJ/EHT165
P577
2013-05-12T00:00:00Z